These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 36112697)

  • 1. The Ethical Implications of Tissue Engineering for Regenerative Purposes: A Systematic Review.
    de Kanter AJ; Jongsma KR; Verhaar MC; Bredenoord AL
    Tissue Eng Part B Rev; 2023 Apr; 29(2):167-187. PubMed ID: 36112697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical considerations in the translation of regenerative biofabrication technologies into clinic and society.
    Otto IA; Breugem CC; Malda J; Bredenoord AL
    Biofabrication; 2016 Oct; 8(4):042001. PubMed ID: 27716629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biofabrication and bioprinting using cellular aggregates, microtissues and organoids for the engineering of musculoskeletal tissues.
    Burdis R; Kelly DJ
    Acta Biomater; 2021 May; 126():1-14. PubMed ID: 33711529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biofabrication: new approaches for tissue regeneration].
    Horch RE; Weigand A; Wajant H; Groll J; Boccaccini AR; Arkudas A
    Handchir Mikrochir Plast Chir; 2018 Apr; 50(2):93-100. PubMed ID: 29378379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical implications of regenerative medicine in orthopedics: an empirical study with surgeons and scientists in the field.
    Niemansburg SL; van Delden JJ; Oner FC; Dhert WJ; Bredenoord AL
    Spine J; 2014 Jun; 14(6):1029-35. PubMed ID: 24184644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomaterial-based 3D bioprinting strategy for orthopedic tissue engineering.
    Chae S; Cho DW
    Acta Biomater; 2023 Jan; 156():4-20. PubMed ID: 35963520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Converging functionality: Strategies for 3D hybrid-construct biofabrication and the role of composite biomaterials for skeletal regeneration.
    Alcala-Orozco CR; Cui X; Hooper GJ; Lim KS; Woodfield TBF
    Acta Biomater; 2021 Sep; 132():188-216. PubMed ID: 33713862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Regenerative Medicine and Biomaterials.
    Şeker Ş; Elçin AE; Elçin YM
    Methods Mol Biol; 2023; 2575():127-152. PubMed ID: 36301474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovative 3D bioprinting approaches for advancing brain science and medicine: a literature review.
    Bocheng X; França R
    Biomed Phys Eng Express; 2024 Sep; 10(6):. PubMed ID: 39260389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State of the Art of Clinical Applications of Tissue Engineering in 2021.
    Paternoster JL; Vranckx JJ
    Tissue Eng Part B Rev; 2022 Jun; 28(3):592-612. PubMed ID: 34082599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photosynthetic microorganisms for the oxygenation of advanced 3D bioprinted tissues.
    Ortega JS; Corrales-Orovio R; Ralph P; Egaña JT; Gentile C
    Acta Biomater; 2023 Jul; 165():180-196. PubMed ID: 35562006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of biotechnological advances and regenerative therapies for endometrial disorders: a systematic review.
    Rodríguez-Eguren A; Bueno-Fernandez C; Gómez-Álvarez M; Francés-Herrero E; Pellicer A; Bellver J; Seli E; Cervelló I
    Hum Reprod Update; 2024 Oct; 30(5):584-613. PubMed ID: 38796750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in 3D bioprinting technology for tissue/organ regenerative engineering.
    Matai I; Kaur G; Seyedsalehi A; McClinton A; Laurencin CT
    Biomaterials; 2020 Jan; 226():119536. PubMed ID: 31648135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commercialization and regulation of regenerative medicine products: Promises, advances and challenges.
    Beheshtizadeh N; Gharibshahian M; Pazhouhnia Z; Rostami M; Zangi AR; Maleki R; Azar HK; Zalouli V; Rajavand H; Farzin A; Lotfibakhshaiesh N; Sefat F; Azami M; Webster TJ; Rezaei N
    Biomed Pharmacother; 2022 Sep; 153():113431. PubMed ID: 36076549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue Engineering and Regenerative Medicine: New Trends and Directions-A Year in Review.
    Gomes ME; Rodrigues MT; Domingues RMA; Reis RL
    Tissue Eng Part B Rev; 2017 Jun; 23(3):211-224. PubMed ID: 28457175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D Bioprinting tissue analogs: Current development and translational implications.
    Liu S; Cheng L; Liu Y; Zhang H; Song Y; Park JH; Dashnyam K; Lee JH; Khalak FA; Riester O; Shi Z; Ostrovidov S; Kaji H; Deigner HP; Pedraz JL; Knowles JC; Hu Q; Kim HW; Ramalingam M
    J Tissue Eng; 2023; 14():20417314231187113. PubMed ID: 37464999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bench to bedside: Current advances in regenerative medicine.
    Clarke G; Harley P; Hubber EL; Manea T; Manuelli L; Read E; Watt FM
    Curr Opin Cell Biol; 2018 Dec; 55():59-66. PubMed ID: 30007127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biofabrication of small diameter tissue-engineered vascular grafts.
    Weekes A; Bartnikowski N; Pinto N; Jenkins J; Meinert C; Klein TJ
    Acta Biomater; 2022 Jan; 138():92-111. PubMed ID: 34781026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.